Journal of Drugs in Dermatology

July 2021 JDD Issue | Special Topic: Skin of Color
JDD Skin of Color IssueWith a special focus on patients with skin of color, the July issue of the Journal of Drugs in Dermatology is packed with outstanding articles, features, and case reports on topics ranging from OTC therapies for hair grow and choosing the right sunscreen in communities of color, to evaluation of a skin of color curriculum for dermatology residents and PLLA for correction of nasolabial folds. Stra …
JDD Skin of Color Issue
Special Focus on Acne and Rosacea
Acne and RosaceaThe June issue of the Journal of Drugs in Dermatology focuses on the topics of acne and rosacea, and features additional articles on topics such as atopic dermatitis and psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Guest Editor James Q. Del Rosso discusses roadblocks that impede patient ability to obtain medications selected by their dermatologist …
Acne and Rosacea
Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline
Periorificial DermatitisBroad spectrum tetracyclines are a well-known, widely used, and often successful treatment for use in inflammatory skin pathologies such as acne and rosacea. However, the steady rise of antibiotic resistance and gut dysbiosis associated with broad spectrum tetracyclines emphasizes the importance and responsibility of antibiotic stewardship. Narrow spectrum antibiotics have become increasingly impo …
Periorificial Dermatitis
Recalcitrant Dyshidrotic Eczema Treated With Dupilumab
eczemaThe following two cases presented by JDD authors Ryan A. Gall MD, John D. Peters MD, and Alyson J. Brinker MD add to the growing literature supporting the use of dupilumab in the treatment of patients with recalcitrant dyshidrotic eczema, both with and without diagnosed contact allergens. Introduction Dyshidrotic eczema, also known as dyshidrosis or pompholyx when involving larger bullae, is a c …
eczema
From COVID-19 Vaccines and Soft Tissue Filler Reactions to Biologic Therapy for Psoriasis
JDD April 2021 IssueThe April issue of the Journal of Drugs in Dermatology features the perfect mix of medical, aesthetic, and surgical dermatology articles on topics ranging from COVID-19 Vaccines and Soft Tissue Filler Reactions to Biologic Therapy for Psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights: A survey was designed to capture the incidence of adverse events in G …
JDD April 2021 Issue